BAFNA PHARMACEUTICALS
|
The Current P/S Ratio of BAFNA PHARMACEUTICALS is 1.46.
Share Price | ₹90.1 | Jul 17,2025 |
Market Cap | ₹213.4 Cr | |
Sales-TTM | ₹145.9 Cr | TTM-Standalone Results |
Price/Sales | 1.46x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of BAFNA PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹213.4 Cr] as on Jul 17,2025
(/) Sales [ ₹145.9 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 1.46x ]
Thus, for BAFNA PHARMACEUTICALS , the investors are currently willing to pay '1.46 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of BAFNA PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of BAFNA PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of BAFNA PHARMACEUTICALS
PS Ratio Performance Analysis for BAFNA PHARMACEUTICALS
- BAFNA PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.21x.
- BAFNA PHARMACEUTICALS 's operated at median p/e ratio of 1.7x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BAFNA PHARMACEUTICALS 's p/e ratio peaked in Mar2021 at 4.56x.
- BAFNA PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 0.05x.
How does BAFNA PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
BAFNA PHARMACEUTICALS | 145.9 | 1.46 | 213.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 52,578.4 | 7.77 | 408,667.0 |
DIVIS LABORATORIES LTD | 9,360.0 | 19.24 | 180,131.0 |
CIPLA LTD | 27,547.6 | 4.35 | 119,745.0 |
TORRENT PHARMACEUTICALS LTD | 11,516.0 | 10.30 | 118,603.0 |
DR REDDYS LABORATORIES LTD | 32,643.9 | 3.23 | 105,429.0 |
MANKIND PHARMA LTD | 12,279.3 | 8.88 | 108,985.0 |
ZYDUS LIFESCIENCES LTD | 23,241.5 | 4.25 | 98,812.2 |
LUPIN LTD | 22,707.9 | 3.93 | 89,310.1 |
AUROBINDO PHARMA LTD | 31,723.7 | 2.11 | 67,021.6 |
ABBOTT INDIA LTD | 6,409.2 | 11.32 | 72,520.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs BAFNA PHARMACEUTICALS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 1.46x |
Max industry PS | 19.24x |
Median industry PS | 4.35x |
Average industry PS | 6.99x |
You may also like the below Video Courses